Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
Includes bibliographical references. === Treatment for drug-resistant tuberculosis (DR-TB) is longer and associated with more significant side-effects than drug susceptible TB. Second line injectable therapy using kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. There...
Main Author: | |
---|---|
Other Authors: | |
Format: | Dissertation |
Language: | English |
Published: |
University of Cape Town
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/10625 |
id |
ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-10625 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-106252020-10-06T05:10:48Z Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa Njuguna, Christine Wanjiku Cox, Helen Boulle, Andrew Epidemiology Includes bibliographical references. Treatment for drug-resistant tuberculosis (DR-TB) is longer and associated with more significant side-effects than drug susceptible TB. Second line injectable therapy using kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. There is a scarcity of literature regarding the frequency of hearing loss as well as associated risk factors, particularly with long term use. This study aimed to determine the incidence and risk factors for hearing loss among patients receiving second line injectable drugs. 2014-12-30T19:49:26Z 2014-12-30T19:49:26Z 2013 Master Thesis Masters MPH http://hdl.handle.net/11427/10625 eng application/pdf University of Cape Town Faculty of Health Sciences Department of Public Health and Family Medicine |
collection |
NDLTD |
language |
English |
format |
Dissertation |
sources |
NDLTD |
topic |
Epidemiology |
spellingShingle |
Epidemiology Njuguna, Christine Wanjiku Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa |
description |
Includes bibliographical references. === Treatment for drug-resistant tuberculosis (DR-TB) is longer and associated with more significant side-effects than drug susceptible TB. Second line injectable therapy using kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. There is a scarcity of literature regarding the frequency of hearing loss as well as associated risk factors, particularly with long term use. This study aimed to determine the incidence and risk factors for hearing loss among patients receiving second line injectable drugs. |
author2 |
Cox, Helen |
author_facet |
Cox, Helen Njuguna, Christine Wanjiku |
author |
Njuguna, Christine Wanjiku |
author_sort |
Njuguna, Christine Wanjiku |
title |
Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa |
title_short |
Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa |
title_full |
Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa |
title_fullStr |
Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa |
title_full_unstemmed |
Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa |
title_sort |
baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (dr-tb) treatment in khayelitsha, south africa |
publisher |
University of Cape Town |
publishDate |
2014 |
url |
http://hdl.handle.net/11427/10625 |
work_keys_str_mv |
AT njugunachristinewanjiku baselineprevalenceandincidenceandriskfactorsfornewonsetdruginducedhearinglossinadultsreceivingdrugresistanttuberculosisdrtbtreatmentinkhayelitshasouthafrica |
_version_ |
1719347223519559680 |